ArticleActa Cardiologica Sinica2026

PCSK9 Inhibitor Attenuates Platelet TLR4 in ACS and TLR4 Blockers Prevent PCSK9-Mediated Platelet Activation.

Lingshan Qi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.